Edition:
United States

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

20.02CNY
26 May 2017
Change (% chg)

¥0.60 (+3.09%)
Prev Close
¥19.42
Open
¥19.45
Day's High
¥20.29
Day's Low
¥19.45
Volume
5,169,842
Avg. Vol
5,427,900
52-wk High
¥27.49
52-wk Low
¥18.09

Latest Key Developments (Source: Significant Developments)

Zhejiang Huahai Pharmaceutical gets official approval from FDA for its product
Monday, 8 May 2017 03:23am EDT 

May 8(Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS> ::* Says it gets official approval for its telmisartan tablets, which is used for primary hypertension treatment, from U.S Food and Drug Administration.* Company will be able to sell its telmisartan tablets in the United States after receiving the FDA approval.  Full Article

Zhejiang Huahai Pharmaceutical gets official approval from FDA for its product
Friday, 28 Apr 2017 04:27am EDT 

April 28 (Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS> ::* Says it gets official approval for its olmesartan medoxomil and hydrochlorothiazide tablets from U.S Food and Drug Administration.  Full Article

Zhejiang Huahai Pharmaceutical to pay cash 1.8 yuan per 10 shares as FY 2016 div payment
Tuesday, 25 Apr 2017 04:58am EDT 

April 25(Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS> : :* Says it plans to pay cash 1.8 yuan per 10 shares as FY 2016 div payment.  Full Article

Zhejiang Huahai Pharma's Q1 profit up after 2016 rise, to set up unit
Monday, 24 Apr 2017 10:07am EDT 

April 24 (Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS>:Says 2016 net profit up 13.2 percent y/y at 500.8 million yuan ($72.74 million).Says Q1 net profit up 15.0 percent y/y at 140.1 million yuan.Says it plans to invest 800 million yuan to set up unit.  Full Article

Zhejiang Huahai's unit to buy Par Pharmaceutical's factory in North Carolina
Tuesday, 6 Dec 2016 04:10am EST 

Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS> :Says unit Prinston Pharmaceutical in deal to buy Par Pharmaceutical's factory in North Carolina's Charlotte for $14 million.  Full Article

Zhejiang Huahai Pharmaceutical gets nod for clinic trial
Thursday, 3 Nov 2016 01:38am EDT 

Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS>:Says it gets China Food and Drug Administration's approval for clinic trial of a capsule used for treatment of depression.  Full Article

Zhejiang Huahai Pharmaceutical to set up medical health investment management JV
Friday, 14 Oct 2016 04:22am EDT 

Zhejiang Huahai Pharmaceutical Co Ltd <600521.SS>: Says it to set up a medical health investment management JV with a Shanghai-based fund management firm .Says the co to hold 50 percent stake in the JV.  Full Article

Zhejiang Huahai Pharmaceutical passes FDA approval
Monday, 15 Aug 2016 10:30pm EDT 

Zhejiang Huahai Pharmaceutical Co., Ltd. <600521.SS>: Says it receives approval for its voriconazole tablets from U.S Food and Drug Administration .Says company will be able to sell its voriconazole tablets in the United States after receiving the FDA approval.  Full Article

Zhejiang Huahai Pharmaceutical to transfer stake in Vivo Panda Fund to unit
Wednesday, 3 Aug 2016 10:08pm EDT 

Zhejiang Huahai Pharmaceutical Co., Ltd. <600521.SS>:Says it plans to transfer 9.97 percent stake in Vivo Panda Fund to its HK-based wholly-owned unit, for $ 10 million.  Full Article

Zhejiang Huahai Pharmaceutical adjusts private placement plan
Monday, 6 Jun 2016 11:37pm EDT 

Zhejiang Huahai Pharmaceutical Co., Ltd. <600521.SS> : Says it amends the private placement plan due to dividend payment .Says new plan is to issue up to 19.6 million new shares at 15.44 yuan per share, for 302.6 million yuan in total.  Full Article

More From Around the Web